This is an example of an EX dataset for selected animals from a nonclinical inhalation study in rats. Subjects were randomized to 1 of 4 dose groups with the test article at dose levels of 0.7, 2.1, and 7.1 mg/kg/day and 1 control group receiving vehicle. The study included 13 weeks of dosing. However, due to severe clinical signs, the dose level for group 4 animals was reduced from 7.1 to 5 during week 6. The other groups remained on the same dose level throughout the study. The animals were placed in inhalation chambers each day for 60 minutes over the 13 weeks period. Prior to first dose and during the study exposure levels were measured by placing a filter for a given time or a set amount of air passing in a port hole in the inhalation chamber. However, the EXDOSE in this inhalation study contain the planned dose level.TOBA-222
-
Getting issue details...STATUSTOBA-221
-
Getting issue details...STATUS
Rows 1-5:
Each animal had 1 record for each exposure period. Volume delivered per porthole is not available so EXVAMT/EXVAMTU variables are not populated. EXDUR was populated with the time the animals are exposed per exposure incident.
Rows 4-5:
Animal 12345-004 had dose reduced from7.1 to 5 mgon day 41 due to clinical signs as explained in the EXADJ variable.
ex.xpt
ex.xpt
Row
STUDYID
DOMAIN
USUBJID
EXSEQ
EXTRT
EXDOSE
EXDOSU
EXDOSFRM
EXROUTE
EXLOT
EXFAST
EXTRTV
EXVAMT
EXVAMTU
EXADJ
EXSTDTC
EXENDTC
EXSTDY
EXENDY
EXDUR
1
12345
EX
12345-001
1
CX2345
0
mg/kg/day
AEROSOL
RESPIRATORY (INHALATION)
Y
5% (w/v) of D-Mannitol in deionized water
2021-06-01
2021-09-01
1
91
PT60M
2
12345
EX
12345-002
2
CX2345
0.7
mg/kg/day
AEROSOL
RESPIRATORY (INHALATION)
AB789.1
Y
5% (w/v) of D-Mannitol in deionized water
2021-06-01
2021-09-01
1
91
PT60M
3
12345
EX
12345-003
3
CX2345
2.1
mg/kg/day
AEROSOL
RESPIRATORY (INHALATION)
AB789.1
Y
5% (w/v) of D-Mannitol in deionized water
2021-06-01
2021-09-01
1
91
PT60M
4
12345
EX
12345-004
4
CX2345
7.1
mg/kg/day
AEROSOL
RESPIRATORY (INHALATION)
AB789.1
Y
5% (w/v) of D-Mannitol in deionized water
2021-06-01
2021-08-15
1
40
PT60M
5
12345
EX
12345-004
5
CX2345
5
mg/kg/day
AEROSOL
RESPIRATORY (INHALATION)
AB789.1
Y
5% (w/v) of D-Mannitol in deionized water
Reduced due to toxicity
2021-08-15
2021-09-01
41
91
PT60M
$warningHtml
Dataset Wrapper Debug Message
Please add a row column to your dataset.
Example: Oral Dosing Reported with 1 Record for Multiple Days of Dosing
This is an example of an EX dataset for selected animals from a typical nonclinical study. In this example, subjects were randomized to 1 of 4 dose groups: the test article at dose levels of 20, 40, and 100 mg/kg/day (single daily administration), and 1 control. The study included 13 weeks of dosing. However, due to severe clinical signs, the dose level for subject 12345004 was reduced from 100 to 75 during week 6. The other subjects remained on the same dose level throughout the study. With respect to timing of doses, the applicant only collected the start and stop dates of uninterrupted periods of dosing.
ex.xpt
ex.xpt
Row
STUDYID
DOMAIN
USUBJID
EXSEQ
EXTRT
EXDOSE
EXDOSU
EXDOSFRM
EXDOSFRQ
EXROUTE
EXLOT
EXTRTV
EXADJ
EXSTDTC
EXENDTC
EXSTDY
EXENDY
1
12345
EX
12345001
1
CX2345
0
mg/kg
SUSPENSION
QD
ORAL GAVAGE
CMC
2007-01-08
2007-04-08
1
91
2
12345
EX
12345002
2
CX2345
20
mg/kg
SUSPENSION
QD
ORAL GAVAGE
AB789.1
CMC
2007-01-08
2007-04-08
1
91
3
12345
EX
12345003
3
CX2345
40
mg/kg
SUSPENSION
QD
ORAL GAVAGE
AB789.1
CMC
2007-01-08
2007-04-08
1
91
4
12345
EX
12345004
4
CX2345
100
mg/kg
SUSPENSION
QD
ORAL GAVAGE
AB789.1
CMC
2007-01-08
2007-02-16
1
40
5
12345
EX
12345004
5
CX2345
75
mg/kg
SUSPENSION
QD
ORAL GAVAGE
AB789.1
CMC
Reduced due to toxicity
2007-02-17
2007-04-09
41
91
$warningHtml
Example: Oral Gavage - 1 Record per Dosing with Multiple Treatments
This is an example of an EX dataset for selected animals from a toxicology study using 2 product exposures and a vehicle control with once-weekly oral administration. Subjects were randomized to 1 of 5 groups. In this example, results are shown for 5 animals, 1 in each group, with 1 record each for the first 2 weeks. For the control group, the EXTRT is listed as the 2 product substances, concatenated with a pipe and zero dose.